Reserved
area
If you do not have user and password contact us

News

Lofarma Biotechnology to fight Ragweed allergy

Lofarma has developed a unique biotechnology to improve the safety profile and bioavailability of Allergen Immunotherapy (AIT) for Ragweed. The treatment is based on a specific chemical modification by which native allergens are modified into monomeric allergoids, adopted for the Monomeric Allergoid Immunotherapy (MAIT).

Read more »